Sienna Biopharmaceuticals, Inc. (SNNAQ)

Sienna Biopharmaceuticals Statistics

Total Valuation

Sienna Biopharmaceuticals has a market cap or net worth of 23.

Market Cap	23
Enterprise Value	n/a

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

Sienna Biopharmaceuticals has 22.78 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	22.78M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+1.23%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	0.00%
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.00, with a Debt / Equity ratio of 0.44.

Current Ratio	4.00
Quick Ratio	2.30
Debt / Equity	0.44
Debt / EBITDA	n/a
Debt / FCF	-0.19
Interest Coverage	-23.99

Financial Efficiency

Return on equity (ROE) is -140.97% and return on invested capital (ROIC) is -49.84%.

Return on Equity (ROE)	-140.97%
Return on Assets (ROA)	-32.10%
Return on Capital (ROIC)	-49.84%
Revenue Per Employee	n/a
Profits Per Employee	-3.69M
Employee Count	13
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	68.36
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	0.02
Average Volume (20 Days)	8,084

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	0.03

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-43.18M
Pretax Income	-52.57M
Net Income	-47.95M
EBITDA	-43.02M
EBIT	-43.18M
Earnings Per Share (EPS)	-1.80

Balance Sheet

The company has 11.33 million in cash and 10.28 million in debt, giving a net cash position of 1.05 million or 0.05 per share.

Cash & Cash Equivalents	11.33M
Total Debt	10.28M
Net Cash	1.05M
Net Cash Per Share	0.05
Equity (Book Value)	23.10M
Book Value Per Share	0.75
Working Capital	14.80M

Cash Flow

In the last 12 months, operating cash flow was -54.63 million and capital expenditures -10,000, giving a free cash flow of -54.64 million.

Operating Cash Flow	-54.63M
Capital Expenditures	-10,000
Free Cash Flow	-54.64M
FCF Per Share	-2.40

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Sienna Biopharmaceuticals does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-31.18%
Shareholder Yield	-31.18%
Earnings Yield	-208,482,608.70%
FCF Yield	-237,560,869.57%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a